Aesica buys UCB plants and signs long-term supply deal
Aesica has bought three manufacturing sites from UCB, making its first foray into continental Europe and more than doubling its production capacity.
Aesica has bought three manufacturing sites from UCB, making its first foray into continental Europe and more than doubling its production capacity.
in-PharmaTechnologist presents five of our top audio-visual articles of 2010, including a map of Pfizer’s plant closures, gangsters in the pharma industry and a look inside SAFC’s HPAPI plant.
Contract service providers continued to move into new geographies in search of more efficient R&D and production in 2010. Here we present five of our most popular articles on the topic, including Pfizer in Asia and the BRIC wall.
CIT and Biomodels have formed a preclinical development partnership they say will benefit drugmakers on both sides of the Atlantic.
Pharmaceuticals robbed by gunmen were recovered by police after hidden tracking devices led authorities to two stolen vans, according to reports.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including a new head of vaccines at Sanofi and another exec moving from Pfizer to AstraZeneca.